AN N-terminal Smac peptide sensitizes human prostate carcinoma cells to methyl jasmonate-induced apoptosis

Cancer Letters

Volumn 302, Issue 1, 2011, Pages 37-46

  Jiang, Guosong ^a   Zhao, Jun ^a   Xiao, Xingyuan ^a   Tao, Dan ^b   Gu, Chaohui ^a   Tong, Qiangsong ^a   Luo, Binfeng ^a   Wang, Liang ^a   Zeng, Fuqing ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Fifth Hospital of Wuhan   (China)

Author keywords

Apoptosis; Inhibitors of apoptosis proteins; Methyl jasmonate; Prostate cancer; Second mitochondria derived activator of caspases

Indexed keywords

CASPASE 9; INHIBITOR OF APOPTOSIS PROTEIN; JASMONIC ACID METHYL ESTER; PROTEIN SMACN7; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CONTROLLED STUDY; DRUG POTENTIATION; DRUG SENSITIZATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; KIDNEY TUBULE EPITHELIUM; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA;

ACETIC ACIDS; AMINO ACID SEQUENCE; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CASPASE 9; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYCLOPENTANES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG SYNERGISM; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MALE; OLIGOPEPTIDES; OXYLIPINS; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

INTRACISTERNAL A-PARTICLES;

EID: 79251600082     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2010.12.009     Document Type: Article

References (46)

1. Desai A.G., Qazi G.N., Ganju R.K., El-Tamer M., Singh J., Saxena A.K., Bedi Y.S., Taneja S.C., Bhat H.K. Medicinal plants and cancer chemoprevention. Curr. Drug Metab. 2008, 9:581-591.
2. Fonseca S., Chico J.M., Solano R. The jasmonate pathway: the ligand, the receptor and the core signalling module. Curr. Opin. Plant Biol. 2009, 12:539-547.
3. Fingrut O., Flescher E. Plant stress hormones suppress the proliferation and induce apoptosis in human cancer cells. Leukemia 2002, 16:608-616.
4. Tong Q.S., Jiang G.S., Zheng L.D., Tang S.T., Cai J.B., Liu Y., Zeng F.Q., Dong J.H. Methyl jasmonate downregulates expression of proliferating cell nuclear antigen and induces apoptosis in human neuroblastoma cell lines. Anticancer Drugs 2008, 19:573-581.
5. Elia U., Flescher E. PI3K/Akt pathway activation attenuates the cytotoxic effect of methyl jasmonate toward sarcoma cells. Neoplasia 2008, 10:1303-1313.
6. Fingrut O., Reischer D., Rotem R., Goldin N., Altboum I., Zan-Bar I., Flescher E. Jasmonates induce nonapoptotic death in high-resistance mutant p53-expressing B-lymphoma cells. Brit. J. Pharmacol. 2005, 146:800-808.
7. Reischer D., Heyfets A., Shimony S., Nordenberg J., Kashman Y., Flescher E. Effects of natural and novel synthetic jasmonates in experimental metastatic melanoma. Brit. J. Pharmacol. 2007, 150:738-749.
8. Flescher E. Jasmonates in cancer therapy. Cancer Lett. 2007, 245:1-10.
9. Rajalingam K., Oswald M., Gottschalk K., Rudel T. Smac/DIABLO is required for effector caspase activation during apoptosis in human cells. Apoptosis 2007, 12:1503-1510.
10. Rotem R., Heyfets A., Fingrut O., Blickstein D., Shaklai M., Flescher E. Jasmonates: novel anticancer agents acting directly and selectively on human cancer cell mitochondria. Cancer Res. 2005, 65:1984-1993.
11. Kim J.H., Lee S.Y., Oh S.Y., Han S.I., Park H.G., Yoo M.A., Kang H.S. Methyl jasmonate induces apoptosis through induction of Bax/Bcl-XS and activation of caspase-3 via ROS production in A549 cells. Oncol. Rep. 2004, 12:1233-1238.
12. Ezekwudo D., Shashidharamurthy R., Devineni D., Bozeman E., Palaniappan R., Selvaraj P. Inhibition of expression of anti-apoptotic protein Bcl-2 and induction of cell death in radioresistant human prostate adenocarcinoma cell line (PC-3) by methyl jasmonate. Cancer Lett. 2008, 270:277-285.
13. Yang Y.L., Li X.M. The IAP family: endogenous caspase inhibitors with multiple biological activities. Cell Res. 2000, 10:169-177.
14. Liston P., Fong W.G., Korneluk R.G. The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene 2003, 22:8568-8580.
15. Du C., Fang M., Li Y., Li L., Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000, 102:33-42.
16. Arnt C.R., Chiorean M.V., Heldebrant M.P., Gores G.J., Kaufmann S.H. Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ. J. Biol. Chem. 2002, 277:44236-44243.
17. Fandy T.E., Shankar S., Srivastava R.K. Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells. Mol. Cancer 2008, 7:60.
18. Stavridi F., Karapanagiotou E.M., Syrigos K.N. Targeted therapeutic approaches for hormone-refractory prostate cancer. Cancer Treat. Rev. 2010, 36:122-130.
19. Krajewska M., Krajewski S., Banares S., Huang X., Turner B., Bubendorf L., Kallioniemi O.P., Shabaik A., Vitiello A., Peehl D., Gao G.J., Reed J.C. Elevated expression of inhibitor of apoptosis proteins in prostate cancer. Clin. Cancer Res. 2003, 9:4914-4925.
20. Nomura T., Yamasaki M., Nomura Y., Mimata H. Expression of the inhibitors of apoptosis proteins in cisplatin-resistant prostate cancer cells. Oncol. Rep. 2005, 14:993-997.
21. Zhang M., Latham D.E., Delaney M.A., Chakravarti A. Survivin mediates resistance to antiandrogen therapy in prostate cancer. Oncogene 2005, 24:2474-2482.
22. Dai Y., Liu M., Tang W., Li Y., Lian J., Lawrence T.S., Xu L. A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB. BMC Cancer 2009, 9:392.
23. Heyfets A., Flescher E. Cooperative cytotoxicity of methyl jasmonate with anti-cancer drugs and 2-deoxy-d-glucose. Cancer Lett. 2007, 250:300-310.
24. Drin G., Cottin S., Blanc E., Rees A.R., Temsamani J. Studies on the internalization mechanism of cationic cell-penetrating peptides. J. Biol. Chem. 2003, 278:31192-31201.
25. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
26. Movsesyan V.A., Yakovlev A.G., Dabaghyan E.A., Stoica B.A., Faden A.I. Ceramide induces neuronal apoptosis through the caspase-9/caspase-3 pathway. Biochem. Biophys. Res. Commun. 2002, 299:201-207.
27. Schmid I., Uittenbogaart C.H., Keld B., Giorgi J.V. A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. J. Immunol. Methods 1994, 170:145-157.
28. Antonarakis E.S., Carducci M.A., Eisenberger M.A. Novel targeted therapeutics for metastatic castration-resistant prostate cancer. Cancer Lett. 2010, 291:1-13.
29. Di Lorenzo G., Buonerba C., Autorino R., De Placido S., Sternberg C.N. Castration-resistant prostate cancer: current and emerging treatment strategies. Drugs 2010, 70:983-1000.
30. Wang G., Reed E., Li Q.Q. Apoptosis in prostate cancer: progressive and therapeutic implications (Review). Int. J. Mol. Med. 2004, 14:23-34.
31. Sanchez A.M., Sanchez M.G., Malagarie-Cazenave S., Olea N., Diaz-Laviada I. Induction of apoptosis in prostate tumor PC-3 cells and inhibition of xenograft prostate tumor growth by the vanilloid capsaicin. Apoptosis 2006, 11:89-99.
32. Ezekwudo D.E., Wang R.C., Elegbede J.A. Methyl jasmonate induced apoptosis in human prostate carcinoma cells via 5-lipoxygenase dependent pathway. J. Exp. Ther. Oncol. 2007, 6:267-277.
33. Yeruva L., Pierre K.J., Bathina M., Elegbede A., Carper S.W. Delayed cytotoxic effects of methyl jasmonate and cis-jasmone induced apoptosis in prostate cancer cells. Cancer Invest. 2008, 26:890-899.
34. Ishii Y., Kiyota H., Sakai S., Honma Y. Induction of differentiation of human myeloid leukemia cells by jasmonates, plant hormones. Leukemia 2004, 18:1413-1419.
35. Probst B.L., Liu L., Ramesh V., Li L., Sun H., Minna J.D., Wang L. Smac mimetics increase cancer cell response to chemotherapeutics in a TNF-alpha-dependent manner. Cell Death Differ. 2010.
36. Lecis D., Drago C., Manzoni L., Seneci P., Scolastico C., Mastrangelo E., Bolognesi M., Anichini A., Kashkar H., Walczak H., Delia D. Novel SMAC-mimetics synergistically stimulate melanoma cell death in combination with TRAIL and Bortezomib. Brit. J. Cancer 2010, 102:1707-1716.
37. Pedersen P.L. The cancer cell's " power plants" as promising therapeutic targets: an overview. J. Bioenergy Biomembr. 2007, 39:1-12.
38. Galluzzi L., Kepp O., Tajeddine N., Kroemer G. Disruption of the hexokinase-VDAC complex for tumor therapy. Oncogene 2008, 27:4633-4635.
39. Goldin N., Arzoine L., Heyfets A., Israelson A., Zaslavsky Z., Bravman T., Bronner V., Notcovich A., Shoshan-Barmatz V., Flescher E. Methyl jasmonate binds to and detaches mitochondria-bound hexokinase. Oncogene 2008, 27:4636-4643.
40. Yeruva L., Elegbede J.A., Carper S.W. Methyl jasmonate decreases membrane fluidity and induces apoptosis through tumor necrosis factor receptor 1 in breast cancer cells. Anticancer Drugs 2008, 19:766-776.
41. Sun C., Cai M., Meadows R.P., Xu N., Gunasekera A.H., Herrmann J., Wu J.C., Fesik S.W. NMR structure and mutagenesis of the third Bir domain of the inhibitor of apoptosis protein XIAP. J. Biol. Chem. 2000, 275:33777-33781.
42. Sun C., Cai M., Gunasekera A.H., Meadows R.P., Wang H., Chen J., Zhang H., Wu W., Xu N., Ng S.C., Fesik S.W. NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP. Nature 1999, 401:818-822.
43. Morizane Y., Honda R., Fukami K., Yasuda H. X-linked inhibitor of apoptosis functions as ubiquitin ligase toward mature caspase-9 and cytosolic Smac/DIABLO. J. Biochem. 2005, 137:125-132.
44. Galban S., Duckett C.S. XIAP as a ubiquitin ligase in cellular signaling. Cell Death Differ. 2010, 17:54-60.
45. Deveraux Q.L., Leo E., Stennicke H.R., Welsh K., Salvesen G.S., Reed J.C. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J. 1999, 18:5242-5251.
46. Guo F., Nimmanapalli R., Paranawithana S., Wittman S., Griffin D., Bali P., O'Bryan E., Fumero C., Wang H.G., Bhalla K. Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis. Blood 2002, 99:3419-3426.